由mRNA编码的泛orthoebolavirus中和抗体有效地防止病毒感染
Pengfei Fan1, Bingjie Sun1, Zixuan Liu1
1Laboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, People's Republic of China.
Emerging microbes & infections
|November 19, 2024
概括
一种新型的人类抗体,2G1通过结合保存的葡萄糖蛋白表位体来向所有orthoebolavirus. 在临床前模型中,基于mRNA的这种抗体的输送显示了对埃博拉病毒和苏丹病毒的强烈交叉中和.
科学领域:
- 病毒学和免疫学 病毒学和免疫学
- 结构生物学 结构生物学
- 疫苗技术 疫苗技术 是一种
背景情况:
- 脊髓炎病毒属包括导致众多疫情的危险病原体.
- 目前用于骨髓炎病毒感染的治疗方法缺乏对不同物种的交叉保护.
- 需要对新出现的菲洛病毒威胁采取广泛的干预措施.
研究的目的:
- 为了识别和表征一种广泛中和的抗体,对orthoebolaviruses.
- 阐明抗体与糖蛋白相互作用的结构基础.
- 开发和评估一种基于mRNA的输送系统,用于抗体治疗.
主要方法:
- 人类衍生抗体的分离和表征 2G1.1.
- 低温电子显微镜测定抗体-GP复合物的结构.
- 在脂质纳米粒子 (LNP) 中封装的编码抗体2G1的mRNA的设计和合成.
- 试管中和化试验和小鼠模型中的体内研究.
主要成果:
- 抗体2G1识别了所有orthoebolavirus物种的糖蛋白 (GP).
- 结构分析显示,2G1结合在GP剪切器上保存的四分体口袋.
- mRNA-2G1-LNP配方在体外对埃博拉病毒和苏丹病毒进行了强大的中和.
- 在小鼠体内给药mRNA-2G1-LNP显示了快速的抗体表达,有效的伪病毒中和,没有观察到肝毒性.
结论:
- 2G1抗体通过向保存的表位体,为对抗orthoebolavirus提供广泛的中和作用.
- mRNA-2G1-LNP代表了一种有希望的,可快速部署的治疗策略,用于骨髓病毒疾病.
- 开发的mRNA框架适用于未来针对病毒病原体的基于抗体的疗法.
相关概念视频
Viruses with RNA Genomes
3
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
3
Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
RNA Interference
25.9K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.9K


